SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-039319
Filing Date
2014-05-15
Accepted
2014-05-15 14:51:54
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-11049_110q.htm 10-Q 811747
2 EX-31.1 a14-11049_1ex31d1.htm EX-31.1 11121
3 EX-31.2 a14-11049_1ex31d2.htm EX-31.2 11075
4 EX-32.1 a14-11049_1ex32d1.htm EX-32.1 7523
  Complete submission text file 0001104659-14-039319.txt   4818071

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xncr-20140331.xml EX-101.INS 557856
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20140331.xsd EX-101.SCH 45638
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xncr-20140331_cal.xml EX-101.CAL 33115
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20140331_def.xml EX-101.DEF 183265
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT xncr-20140331_lab.xml EX-101.LAB 721983
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20140331_pre.xml EX-101.PRE 340997
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 14846364
SIC: 2834 Pharmaceutical Preparations